Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada
Abstract
Introduction and Aims: A previous observational study of ayahuasca‐assisted therapy demonstrated statistically significant reductions in self‐reported problematic cocaine use among members of an Indigenous community in Canada. This paper aims to qualitatively explore the impact of ayahuasca‐assisted therapy on addiction and other substance use‐related outcomes and elucidate the lived experiences of participants. Design and Methods: Qualitative interviews were conducted with 11 adult Indigenous participants of the ayahuasca‐assisted ‘Working with Addiction and Stress’ ceremonial retreats (June–September 2011). Semi‐structured interviews assessed experiences of participants following the retreats at 6‐month follow up. Thematic analysis of interview transcripts was conducted. Results: Narratives revealed that the retreats helped participants identify negative thought patterns and barriers related to their addiction in ways that differed from conventional therapies. All participants reported reductions in substance use and cravings; eight participants reported complete cessation of at least one substance at follow up. Increased connectedness with self, others and nature/spirit was described as a key element associated with reduced substance use and cravings. Discussion and Conclusions: This analysis expands upon prior quantitative results highlighting the therapeutic potential of ayahuasca‐assisted therapy and provides important contextual insights into why ayahuasca‐assisted therapy may have been beneficial for members of an Indigenous community seeking to address their problematic use of substances. Given limited efficacy of conventional treatments for resolving addiction issues, further research should investigate the role of ayahuasca and other psychedelic‐assisted therapies in enhancing connectedness and other key factors that may improve well‐being and reduce harmful substance use.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In qualitative interviews, participants identified increased connectedness to oneself, others, and the world as a key element underlying the therapeutic effect of psychedelic-assisted therapy, including reduced craving and substance use in individuals with addiction.
“In qualitative interviews, participants identified this tri-dimensional factor as a key element underlying the therapeutic effect of PAT [61, 62], including reduced craving and substance use in individuals with addiction [62].”
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414 · see citing works
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · see citing works
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · see citing works
Indigenous health part 1: Determinants and disease patterns
Gracey, M., & King, M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60914-4 · Cited by 1,303 · see citing works
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · see citing works
Pilot study of the 5-HT <sub>2A</sub> R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · see citing works
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852 · see citing works
Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · see citing works
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583 · see citing works
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488 · see citing works
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476 · see citing works
Gasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456 · see citing works
Mindfulness treatment for substance misuse: A systematic review and meta-analysis
Li, W., Howard, M. O., Garland, E. L., McGovern, P., & Lazar, M. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.008 · Cited by 446 · see citing works
Oehen, P., Traber, R., Widmer, V., & Schnyder, U. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112464827 · Cited by 402 · see citing works
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar‐Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 376 · see citing works
Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D., & Johnson, M. W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565653 · Cited by 360 · see citing works
School Connectedness: Strategies for Increasing Protective Factors Among Youth
(2009) · PsycEXTRA Dataset · doi:10.1037/e568202009-001 · Cited by 344 · see citing works
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338 · see citing works
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada
Thomas, G., Lucas, P., Capler, N., Tupper, K., & Martin, G. (2013) · Current Drug Abuse Reviews · doi:10.2174/15733998113099990003 · Cited by 330 · see citing works
Self-citationKraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.010 · Cited by 323 · see citing works
dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306 · see citing works
The paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293 · see citing works
Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts
Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780612 · Cited by 285 · see citing works
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00576-3 · Cited by 239 · see citing works
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237 · see citing works
Assessment of addiction severity among ritual users of ayahuasca.
Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227 · see citing works
Treatment of Acute Opioid Withdrawal with Ibogaine
Alper, K., Lotsof, H. S., Frenken, G. M. N., Luciano, D., & Bastiaans, J. (1999) · American Journal on Addictions · doi:10.1080/105504999305848 · Cited by 202 · see citing works
Psychedelic medicine: a re-emerging therapeutic paradigm
Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.141124 · Cited by 187 · see citing works
Self-citationLoizaga-Velder, A. K., & Verres, R. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.873157 · Cited by 157 · see citing works
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Hendricks, P. S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1474185 · Cited by 151 · see citing works
Sieving, R. E., McRee, A., McMorris, B. J., Shlafer, R. J., Gower, A. L., Kapa, H. M., Beckman, K. J., Doty, J. L., Plowman, S. L., & Resnick, M. D. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.07.037 · Cited by 149 · see citing works
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
Johnson, M. W., Garcia‐Romeu, A., Johnson, P. S., & Griffiths, R. R. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116684335 · Cited by 129 · see citing works
Bogenschutz, M. P., & Pommy, J. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1376 · Cited by 125 · see citing works
Ibogaine in the Treatment of Substance Dependence
Brown, T. (2013) · Current Drug Abuse Reviews · doi:10.2174/15672050113109990001 · Cited by 104 · see citing works
Chapter 8 Ibogaine in the treatment of heroin withdrawal
Mash, D. C., Kovera, C. A., Pablo, J. P., Tyndale, R. F., Ervin, F. R., Kamlet, J. D., & Hearn, W. L. (2001) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/s0099-9598(01)56012-5 · Cited by 93 · see citing works
Are family warmth and positive remarks related to outcomes in psychosis? A systematic review
Butler, R., Berry, K., Varese, F., & Bucci, S. (2018) · Psychological Medicine · doi:10.1017/s0033291718003768 · Cited by 77 · see citing works
Shaping the renaissance of psychedelic research
Sessa, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60600-x · Cited by 66 · see citing works
Calabrese, J. D. (2013) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199927722.001.0001 · Cited by 43 · see citing works
A different medicine: postcolonial healing in the Native American Church
(2013) · Choice Reviews Online · doi:10.5860/choice.51-1572 · Cited by 40 · see citing works
Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?
da Cruz, J. I., & Nappo, S. A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1447174 · Cited by 36 · see citing works
Mustain, J. R., & Helminiak, D. A. (2015) · Addiction Research & Theory · doi:10.3109/16066359.2015.1011623 · Cited by 12 · see citing works
Dawson, A. (2016) · Routledge eBooks · doi:10.4324/9781315551425-8 · Cited by 9 · see citing works
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Watts, R., Kettner, H., Geerts, D., Gandy, S., Kärtner, L., Mertens, L. J., Timmermann, C., Nour, M. M., Kaelen, M., Nutt, D., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06187-5 · Cited by 169 · see citing works
dos Santos, R. G., & Hallak, J. E. C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.001 · Cited by 111 · see citing works
Moula, Z., Palmer, K., & Walshe, N. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.858781 · Cited by 75 · see citing works
Mendes, F. R., Costa, C. D. S., Wiltenburg, V. D., Morales-Lima, G., Fernandes, J. A. B., & Filev, R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100025 · Cited by 59 · see citing works
Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
Mosurinjohn, S. C., Roseman, L., & Girn, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1077311 · Cited by 57 · see citing works
Perkins, D., Opaleye, E. S., Šimonová, H., Bouso, J. C., Tófoli, L. F., Coelho, N. L. G., Schubert, V., & Sarris, J. J. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13348 · Cited by 54 · see citing works
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
Ruffell, S., Crosland‐Wood, M., Palmer, R., Netzband, N., Tsang, W., Weiss, B., Gandy, S., Cowley‐Court, T., Halman, A., McHerron, D., et al. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.146 · Cited by 54 · see citing works
Ayahuasca's therapeutic potential: What we know – and what not
Maia, L. O., Daldegan‐Bueno, D., Wießner, I., de Araújo, D. B., & Tófoli, L. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.008 · Cited by 47 · see citing works
Sang, Å. O., Thorpert, P., & Fransson, A. (2022) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2022.804500 · Cited by 50 · see citing works
Kałużna, A., Schlosser, M., Craste, E. G., Stroud, J., & Cooke, J. E. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00199 · Cited by 44 · see citing works
Mattosinhos, P. D. S., Sarandy, M. M., Novaes, R. D., Esposito, D., & Gonçalves, R. V. (2022) · Antioxidants · doi:10.3390/antiox11071346 · Cited by 43 · see citing works
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Markopoulos, A., Inserra, A., De Gregorio, D., & Gobbi, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749068 · Cited by 46 · see citing works
Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice
Almeida, C. A. D. F., Pereira-Júnior, A. A., Rangel, J. G., Pereira, B. P., Costa, K. C. M., Bruno, V., Silveira, G. D. O., Ceron, C. S., Yonamine, M., Camarini, R., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113546 · Cited by 35 · see citing works
The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study
Maia, L. O., Daldegan-Bueno, D., & Tófoli, L. F. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1854399 · Cited by 32 · see citing works
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 33 · see citing works
Racial Stress, Racial Trauma, and Evidence-Based Strategies for Coping and Empowerment
Holmes, S. C., Zare, M., Haeny, A. M., & Williams, M. T. (2024) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081122-020235 · Cited by 38 · see citing works
Lake, S., & Lucas, P. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2023.0002 · Cited by 34 · see citing works
Self-citationArgento, E., Socias, M. E., Hayashi, K., Choi, J., Mackay, L., Christie, D., Milloy, M., & DeBeck, K. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103518 · Cited by 33 · see citing works
Self-citationWithin-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
O’Shaughnessy, D. M., Berlowitz, I., Rodd, R., Sarnyai, Z., & Quirk, F. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320986634 · Cited by 33 · see citing works
Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil
Daldegan‐Bueno, D., Maia, L. O., Massarentti, C. M., & Tófoli, L. F. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06063-2 · Cited by 32 · see citing works
Sharma, R., Batchelor, R., & Sin, J. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2190319 · Cited by 30 · see citing works
Rush, B. R., Marcus, O., García, S., Loizaga-Velder, A. K., Loewinger, G. C., Spitalier, A., & Mendive, F. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659644 · Cited by 29 · see citing works
Serra, Y. A., Barros-Santos, T., Anjos-Santos, A., Kisaki, N. D., Jovita-Farias, C., Leite, J. P., Santana, M. C. E., Coimbra, J. P. S. A., de Jesus, N. M. S., Sulima, A., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06104-w · Cited by 27 · see citing works
Perkins, D., Ruffell, S., Day, K., Rubiano, D. P., & Sarris, J. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.879221 · Cited by 30 · see citing works
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 28 · see citing works
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2077155 · Cited by 24 · see citing works
Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia
Irvine, A., Luke, D. P., Harrild, F., Gandy, S., & Watts, R. (2023) · Psychoactives · doi:10.3390/psychoactives2020012 · Cited by 24 · see citing works
Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”
O’Shaughnessy, D. M., & Berlowitz, I. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639124 · Cited by 22 · see citing works
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Richard, J., & Garcia‐Romeu, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00629-8 · Cited by 19 · see citing works
Forstmann, M., Kettner, H., Sagioglou, C., Irvine, A., Gandy, S., Carhart-Harris, R. L., & Luke, D. P. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811221146356 · Cited by 19 · see citing works
Cowley‐Court, T., Chenhall, R. D., Sarris, J. J., Bouso, J. C., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2023) · Psychoactives · doi:10.3390/psychoactives2020014 · Cited by 20 · see citing works
Hogea, L., Tabugan, D. C., Costea, I., Albai, O., Nussbaum, L. A., Cojocaru, A., Corsaro, L., & Anghel, T. (2025) · Medicina · doi:10.3390/medicina61020278 · Cited by 19 · see citing works
Co-use of psychedelics with other substances: Findings from the global psychedelic survey
Lake, S., & Lucas, P. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241292956 · Cited by 17 · see citing works
Self-citationGlynos, N. G., Aday, J. S., Kruger, D. J., Boehnke, K. F., Lake, S., & Lucas, P. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1349565 · Cited by 17 · see citing works
Self-citationWalther, R. F. E., & van Schie, H. T. (2024) · Psychoactives · doi:10.3390/psychoactives3030026 · Cited by 20 · see citing works
Daldegan‐Bueno, D., Révész, D., Morais, P. R., Barbosa, P. C. R., & Maia, L. O. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2063896 · Cited by 17 · see citing works
Lyon, A. (2023) · doi:10.1093/oso/9780198843757.001.0001 · Cited by 17 · see citing works
Apud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2053004 · Cited by 14 · see citing works
Rush, B. R., Marcus, O., García, S., Loizaga-Velder, A. K., Spitalier, A., & Mendive, F. M. (2023) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.23-00005 · Cited by 14 · see citing works
Wong, S., Yu, A. Y., Fabiano, N., Finkelstein, O., Pasricha, A., Jones, B. D. M., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Husain, M. I. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2251133 · Cited by 14 · see citing works
David, J., Bouso, J. C., Kohek, M., Oña, G., Tadmor, N., Arnon, T., Dor‐Ziderman, Y., & Berkovich‐Ohana, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1287961 · Cited by 12 · see citing works
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05502-y · Cited by 13 · see citing works
“In qualitative interviews, participants identified this tri-dimensional factor as a key element underlying the therapeutic effect of PAT [61, 62], including reduced craving and substance use in individuals with addiction [62].”
BackgroundSagioglou, C., & Forstmann, M. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221129803 · Cited by 12 · see citing works
Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts
Graziosi, M., Singh, M., Nayak, S. M., & Yaden, D. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2255274 · Cited by 11 · see citing works
Spending Time in Nature: The Overlooked Health Behavior
Maddock, J. E., & Johnson, S. S. (2023) · American Journal of Health Promotion · doi:10.1177/08901171231210806 · Cited by 14 · see citing works
Ruffell, S. G. D., Gandy, S., Tsang, W.-F., López, R., O'Rourke, N., Akhtar, A., Netzband, N., Hollingdale, J., Perkins, D., & Sarris, J. (2024) · Drug Science Policy and Law · doi:10.1177/20503245241235100 · Cited by 10 · see citing works
Changed Substance Use After Psychedelic Experiences Among Individuals in Canada
Boehnke, K. F., Kruger, D. J., & Lucas, P. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01085-z · Cited by 12 · see citing works
Self-citationGraham, O. J., Rojas, G. S., & Politi, M. (2022) · Anthropology of Consciousness · doi:10.1111/anoc.12170 · Cited by 11 · see citing works
Chaves, C., SANTOS, R. G. D., Dursun, S. M., Tusconi, M., Carta, M. G., Brietzke, E. M., & Hallak, J. E. C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1485337 · Cited by 11 · see citing works
Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis
van der Heijden, K. V., Otto, M. E., Schoones, J. W., van Esdonk, M. J., Borghans, L. G. J. M., van Hasselt, J. G. C., van Gerven, J., & Jacobs, G. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01450-8 · Cited by 11 · see citing works
Loizaga-Velder, A. K., Giovannetti, C., Gomez, R. C., Valenzuela, T. C., Jaime, G. R. O., Agin-Liebes, G., Marcus, O., & Rush, B. R. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2255182 · Cited by 10 · see citing works
Weleff, J., Nunes, J. C., Costa, G. P. A., Sofuoglu, M., MacLean, R. R., & Aquino, J. P. D. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16045 · Cited by 11 · see citing works
Brandt, J. (2023) · Drug Science Policy and Law · doi:10.1177/20503245231170340 · Cited by 7 · see citing works
Ayahuasca for the treatment of alcohol use disorder
Marinho, E. A. V., Serra, Y. A., Oliveira-Lima, A. J., Marcourakis, T., & Berro, L. F. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.07.007 · Cited by 7 · see citing works
Zuk, A. M., Ahmed, F., Charania, N. A., Sutherland, C., Kataquapit, G., Moriarity, R. J., Spence, N. D., Tsuji, L. J. S., & Liberda, E. N. (2024) · Dialogues in Health · doi:10.1016/j.dialog.2024.100190 · Cited by 6 · see citing works
Argento, E., Capler, R., THOMAS, G. W., Lucas, P., & Tupper, K. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_10 · Cited by 6 · see citing works
Self-citationApud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00202 · Cited by 6 · see citing works
Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review
Viljoen, G., Walter, H., Bendau, A., Koslowski, M., & Betzler, F. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251389581 · Cited by 5 · see citing works
Impact of psychedelics on craving in addiction: A systematic review
Chapron, S., Bonazzi, G., Lodovico, L. D., de Ternay, J., Landmann, C., Nourredine, M., Salvo, F., Sessa, B., Das, R., Rolland, B., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811241308613 · Cited by 5 · see citing works
Argento, E., Goldenberg, S. M., Deering, K., Lavalley, J., Braschel, M. C., Bingham, B., & Shannon, K. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100044 · Cited by 5 · see citing works
Self-citationUsing Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
Tariq, R. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220321142707 · Cited by 5 · see citing works
Bhatt, S. R., Armstrong, M., Parker, T., Maviglia, M. A., Kass, R., Leeman, L. M., Romo, P., & Ziedonis, D. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905753 · Cited by 6 · see citing works
Richard, J., Scott, J., Nayak, S. M., Sepeda, N. D., Lowe, M. X., Jackson, H., & Garcia‐Romeu, A. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-025-01489-z · Cited by 4 · see citing works
Traditional Amazonian medicine in addiction treatment: Qualitative results
O’Shaughnessy, D. M., Sarnyai, Z., Quirk, F. H., & Rodd, R. (2022) · SSM - Qualitative Research in Health · doi:10.1016/j.ssmqr.2022.100086 · Cited by 3 · see citing works
Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use
Kruger, D. J., Albrecht, J., Aday, J. S., Barron, J., Herberholz, M., & Boehnke, K. F. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2461999 · Cited by 3 · see citing works
Savoldi, R., Roazzi, A., Escobar, J. A. C., Nour, M. M., & Carhart-Harris, R. L. (2023) · International Journal of Latin American Religions · doi:10.1007/s41603-023-00203-y · Cited by 2 · see citing works
Matoc, M. S., Stiperski, Z., & Hruška, T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003821 · Cited by 2 · see citing works
Effective factors of addiction treatment communities in Peru, Nicaragua and Czechia
Horák, M., Somerlíková, K., Kočárová, R., Verter, N., González, H., & Tronco, M. C. D. S. (2021) · Therapeutic Communities The International Journal of Therapeutic Communities · doi:10.1108/tc-06-2020-0013
Fu, C.-C. A., Morales, M. L., & Cabada, M. M. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa142 · Cited by 2 · see citing works
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0009 · Cited by 1 · see citing works
Rich, R., Laird, K. T., Siddarth, P., Youssef, B., Schwartz, G. M., Ramos, A., Sergi, K., Linton, M., Schwartzberg, L., Kelly, D. F., et al. (2025) · Psychedelic Medicine · doi:10.1177/28314425251387655 · Cited by 1 · see citing works
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0001 · Cited by 1 · see citing works
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0005 · Cited by 1 · see citing works
Psychedelic Healing: A Historical, Empirical, and Personal Account
Swoap, R. (2023) · American Journal of Health Promotion · doi:10.1177/08901171231210806e · Cited by 1 · see citing works
Sekula, A. D., Puspanathan, P., Downey, L. A., & Liknaitzky, P. (2024) · Psychoactives · doi:10.3390/psychoactives3020010 · Cited by 1 · see citing works
Apud, I. (2023) · Studies in Psychology Estudios de Psicología · doi:10.1080/02109395.2022.2163776 · Cited by 1 · see citing works
Perkins, D., Ruffell, S., Day, K., Pinzon, D., & Sarris, J. J. (2022) · doi:10.31219/osf.io/e5tjc · Cited by 1 · see citing works
ルポ 昼休みを生かしてリフレッシュ--東京急行電鉄(株)車両部長津田検車区 (作業の合間でリフレッシュ--休憩時間の過ごし方のヒント )
労働衛生編集部 (1995) · 労働衛生
Characteristics of Investigated TCs
Horák, M., & Verter, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-16459-0_3
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0010
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0011
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0008
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0012
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0007
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0003
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0004
What Is Psychedelic Experience?
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0002
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0005
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0003
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3829237/v1
Psychedelics for the Treatment of Substance Use Disorders: A Narrative Review of the Literature
Marcus, O., & Rush, B. R. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251351123
Apud, I., Scuro, J., Lozano, F., Retta, J. I., & Carrera, I. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00496
Maar, M. A., Boesch, L., Martell, R., Manitowabi, D., McGregor, L., Evans, C., Williamson, P., & Eshkakogan, C. (2026) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2026.2681541
The Value of Diverse Knowledge Systems in Understanding and Responding to Addictions
Adams, P. J., Lyons, A., & Ramalho, R. (2026) · Contemporary Drug Problems · doi:10.1177/00914509261470190
The Australian Ayahuasca Dietero Networks: Culture, Community, and Practices
Roy, A., Williams, M. L., Day, K., & Barratt, M. J. (2026) · Contemporary Drug Problems · doi:10.1177/00914509261473569
- Authors
- Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W.
- Affiliations
- University of British Columbia (CA)
- British Columbia Centre on Substance Use (CA)
- University of Victoria (CA)
- Corresponding author
- Thomas, Gerald
- Venue
- Drug and Alcohol Review
- Publisher
- Wiley
- Published
- 2019-09-05
- Volume
- 38
- Issue
- 7
- Pages
- 781-789
- ISSN
- 0959-5236 (ISSN-L)
- 1465-3362
- OpenAlex
- W2971496197
- Cited by
- 102
- References
- 44
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 36 · 2022: 24 · 2021: 8 · 2020: 4 · 2019: 1
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug and Alcohol Review (publishedVersion)
- PubMed (publishedVersion)
- Funders
- River Styx Foundation
- TIDES Canada
- Riverstyx Foundation
- Dr. Bronner's Soaps
- Multidisciplinary Association for Psychedelic Studies
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psychedelic therapy, addiction, cocaine use, indigenous peoples, lived experience, substance use reduction, craving, connectedness
- MeSH terms
- Indigenous Peoples, Adult, Canada, Female, Follow-Up Studies, Humans, Interviews as Topic, Male, Middle Aged, Treatment Outcome, Substance-Related Disorders, Plant Preparations, Banisteriopsis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review